More impact of microalbuminuria on retinopathy than moderately reduced GFR among type 2 diabetic patients.
More impact of microalbuminuria on retinopathy than moderately reduced GFR among type 2 diabetic patients.
复制标题
DOI:
10.2337/dc11-1955
复制
发表时间:
2012-04
期刊:
影响因子:
16.2
通讯作者:
Tarng DC
中科院分区:
文献类型:
--
作者:
Chen YH;Chen HS;Tarng DC
The current study aimed to investigate whether microalbuminuria or moderately decreased glomerular filtration rate (GFR) is a better predictor for the development and progression of retinopathy in type 2 diabetic patients. Type 2 diabetic patients without cardiovascular diseases, malignancy, pregnancy, and acute intercurrent illness were enrolled between 1 August 2001 and 31 December 2002. All participants provided their detailed medical history and underwent an eye fundus examination. They were followed up in outpatient clinics, and serum creatinine, urinary albumin-to-creatinine ratio (UACR), and retinal photographs were followed up annually until 31 December 2009. The primary outcomes were development and progression of diabetic retinopathy and nephropathy. The secondary outcomes were cardiovascular events and all-cause mortality. Among 487 participants, 81 subjects had normoalbuminuria and moderate renal impairment (baseline eGFR 30–59.9 mL/min/1.73 m2), and 106 subjects had microalbuminuria and baseline eGFR ≥60 mL/min/1.73 m2. Patients with microalbuminuria and eGFR ≥60 mL/min/1.73 m2 had a significantly greater risk for development and progression of diabetic retinopathy (HR 3.34 [95% CI 1.04–10.70]) compared with those with moderate renal impairment and normoalbuminuria after multivariate adjustment. Risks for renal outcome, cardiovascular events, and all-cause mortality were not significantly different between the two groups. Microalbuminuria has a greater impact on predicting the development and progression of diabetic retinopathy compared with moderate decline in GFR among type 2 diabetic patients.
登录
查看更多内容
DOI:
10.1056/nejmoa1001288
发表时间:
2010-07-15
期刊:
The New England journal of medicine
影响因子:
--
作者:
ACCORD Study Group;ACCORD Eye Study Group;Chew EY;Ambrosius WT;Davis MD;Danis RP;Gangaputra S;Greven CM;Hubbard L;Esser BA;Lovato JF;Perdue LH;Goff DC Jr;Cushman WC;Ginsberg HN;Elam MB;Genuth S;Gerstein HC;Schubart U;Fine LJ
通讯作者:
Fine LJ
影响因子:
15.9
作者:
Mizutani, M;Kern, TS;Lorenzi, M
通讯作者:
Lorenzi, M
影响因子:
16.2
作者:
MacIsaac, R;Tsalamandris, C;Jerums, G
通讯作者:
Jerums, G
影响因子:
5.1
作者:
Tone, A;Shikata, K;Makino, H
通讯作者:
Makino, H
影响因子:
8.2
作者:
Stratton, IM;Kohner, EM;Matthews, DR
通讯作者:
Matthews, DR